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The research in this dissertation has shown widespread and prolonged 
discrimination in provision of healthcare to South Asian patients with 
chronic gastrointestinal diseases. The data, which forms the basis for the 
analysis, were collected using different techniques, in different places and at 
different times. The consistency of the findings reinforces their reliability. 
In the initial study, a cohort of newly diagnosed patients with ulcerative 
colitis was assessed over a 10-year period. South Asian patients were less 
likely to see a consultant, underwent less investigations and were more 
likely to be discharged. Subsequent studies showed South Asian patients 
with Crohn’s disease were less likely to receive expensive biologic 
therapies. These studies reviewed treatment registers and data generated 
from Freedom of Information requests. In the case of achalasia, the first 
study of its incidence in the South Asian community showed it to be of 
comparable frequency to White British people. The first meta-analysis of 
cancer frequency demonstrated the risk to increase progressively with time, 
although no specific information for the South Asian community could be 
extracted. However, a review of treatment modalities demonstrated South 
Asians with achalasia were significantly more likely to receive novel 
treatments given by practitioners on the early part of their learning curve. 
Despite objective evidence for substandard care given to South Asian 
patients, trusts and associated monitoring bodies, where this happened, 
denied the reality of the findings and reported no appropriate adjustments. 
National bodies with statutory responsibility for ensuring equitable care 
could provide no examples of actions which they had taken to remedy such 
situations. A review of legal options through which poorer care for South 
Asian patients could be addressed failed to identify any effective remedies 
and proposed that the only effective option available was through the tort of 
negligence. Potential methods of improving this situation are discussed. 
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“Of all the forms of inequality, injustice in health is the most shocking 
 and inhuman.”  (Martin Luther King Jr, 1966) (Munro, 2016) 
 
This chapter will deal with the recognition of disparate care for black and 
ethnic minority (BEM) communities in the UK. It will consider the 
approach to equality of care developed within the National Health Service 
(NHS) and the effectiveness of monitoring by statutory government bodies. 
Documented examples of disparate care in various diseases in the UK will 
be noted and the rationale for studies in Leicester explained, together with 
the choice of gastrointestinal diseases as an exemplar. 
Issues around equality of access to healthcare had been of concern in the 
UK since the time of the Webbs. On 6 March 1911 Beatrice Webb wrote in 
her diary: 
“What we are trying to achieve is to direct the sickness insurance 
scheme into a big reconstruction of public health” 
Their work on this reconstruction, together with that of other social 
reformers, led to the foundation of the National Health Service (NHS) on 5 
July 1948 through the determined efforts of Nye Bevan. In 1958, during a 
debate in the House of Commons, he spoke of its purpose: 
“Many people have died and many have suffered not because the 
knowledge was not there, but because they did not have access to it. 
To all the suffering which attends illness, there was always added the 
bitterness that, if the poor could have had access to the knowledge 
available, they might have been saved, or at least, might have been 
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helped. It was this situation that the National Health Service was 
intended to put right.” (Bevan, 1958) 
This concept of free and open access to healthcare in the United Kingdom 
was a basic principle of the NHS.  
Ethnicity and Healthcare in the UK: 
However, thirty years after the foundation of the NHS, a Royal Commission 
on the NHS was of the view that there were special demands from “an aged, 
migrant or homeless population” (Merrison, 1979). The Commission went 
on to say:    
“The special needs of patients who come from ethnic minorities 
require sensitive handling by the NHS.” (Merrison, 1979 7.61) 
This was a sign of an emerging awareness of different BEM health needs. It 
was to result in qualitative and quantitative studies looking at access to 
healthcare by patients from these populations.  As early as 1964, Patterson 
had drawn attention to the additional medical needs of children of Afro-
Caribbean origin. In the early 1980s, there was recognition of the 
emergence of non-insulin dependent diabetes amongst Afro-Carribean 
communities in London (Nikolaides et al, 1981) and later in 
Wolverhampton (Odugbesan et al, 1989).  In 1980, Terry, Condie and 
Settatree drew attention to the high rate of stillbirths and perinatal mortality 
amongst South Asian women compared to Afro-Caribbean and European 
mothers for the first time. In 1984, McFadyen et al reported that the 
children of South Asian patients, from both India and East Africa and born 
at Northwick Park Hospital, Harrow, were significantly lighter in weight 
than those with European parents.  
Interest during the 1980s had started to focus on the South Asian 
community in the UK. During the 1960s South Asians had come to the UK 
to work in various industries, such as clothing in Leicester and brick 
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making in Peterborough (Jaspal, 2015). In 1972, almost 60,000 South Asian 
citizens were expelled en masse from Uganda (Jamal, 1976). Together with 
people from Kenya, Tanzania and Malawi, it is estimated that from the 
early 1960s to the mid-1970s between 150,000 and 200,000 South Asians 
had settled in the UK (Anders, Burgess and Portes, 2018). About 20,000  
people, who had been expelled from Uganda, settled in Leicester and so by 
1981 the South Asian population of the city was almost 60,000 (Marrett, 
1989). The city’s South Asian community now comprises at least 37% of 
the population (Leicester Population, 2020) and most of the studies 
presented in this submission were based in Leicester.  Indeed, by 2018 the 
South Asian ethnic groups made up the second largest percentage of the 
population throughout the UK (7.5%) (National Ethnicity Data, undated). 
Studies across the United Kingdom began to examine the experience of 
patients from South Asian and other BEM communities who had diabetes, 
breast cancer and coronary artery disease. Comparisons were made with the 
experience of contemporaneous White patients and so management and care 
issues that had previously been overlooked were identified. Coronary artery 
disease drew particular interest from researchers, possibly because of its 
high morbidity and mortality 
South Asian patients in Leicester, who were at greater risk of coronary 
artery disease than the White British population, were experiencing 
significant delays in diagnosis and receiving appropriate treatment, so 
resulting in poorer outcomes (Lear et al i and ii, 1994). Similar findings 
were also reported from Newham in London (Wilkinson et al, 1996). 
Unfortunately, the impact of the work by Lear et al (i and ii, 1994) was 
damaged by the retraction of a subsequent study from the same unit due to 
“deliberately entered false data into the study in order to produce a 
particular result.” (Shaukat et al, 1997, Dyer, 2003) The overall impact of 
Shaukat et al’s (1997) study on publications into discriminatory and 
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disparate care was likely to have been unfavourable. However, the original 
observations by Lear et al (i and ii, 1994) remain valid. For example, delays 
in arrival at hospital and delays in interventions to manage myocardial 
infarction in South Asian patients continue to be an issue, as demonstrated 
in a recent study from Birmingham (Kendall et al, 2012). Indeed, there is a 
disparity in implantable cardioverter defibrillator therapy, which is 
significantly lower for South Asians than White British patients, in the 
United Kingdom (Mistry et al, 2020). Mistry et al (2020) were unable to 
determine whether this difference was due to “cultural acceptance or an 
unbalanced consideration”. However, it is of interest that the National 
Institute for Health and Care Excellence (NICE) recently estimated that the 
cost of such a defibrillator and its maintenance, over a 15-year period, 
ranged between £28,000 and £34,000 (NICE, 2017).  
Diabetes also emerged as a major problem in the South Asian community. 
In 2004, a study of 734 South Asian diabetic patients in Southall showed a 
markedly increased predisposition to cardiovascular disease compared with 
Europeans, especially in younger people (Mather, Chaturvedi and Fuller, 
1998). However, there have been few studies which have examined the 
nature and quality of care received by South Asian patients with diabetes in 
the long-term. One such report from Nottingham showed South Asian 
patients with diabetes were less likely to have either their blood pressure or 
serum creatinine checked by general practitioners over the limited period of 
1 year (Christopher and Kendrick, 2004).  
Differences in the nature of the support and treatment offered to women 
from South Asian communities can also be seen in the management of 
breast cancer. In one study, Pakistani women were less likely to be offered 
radiotherapy or hormone treatment than White women (Jack, Davies and 
Møller, 2009). A systematic review of the poor uptake of breast and 
cervical cancer screening by South Asian women concluded that incorrect 
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addresses, language and cultural barriers were significant factors (Sokal, 
2010) and this continues to be the case (Woof et al, 2020). The National 
Cancer Patient Experience Survey (2018) reported Asian patients’ rating of 
their overall experience of care was the lowest, followed by Black patients, 
compared to all other groups. There is a recurring tendency by researchers 
and policy makers to attribute such differences in cancer care to social and 
cultural factors (Chouhan and Nazroo, 2020 p. 91). However, such issues 
are not unique to cancer and a recent study on culturally competent care for 
South Asian patients with inflammatory bowel disease recognised that 
gastroenterology services failed to address barriers to utilising services 
(Mukherjee et al, 2020). For example, the simple provision of adequate 
translation services has been shown to have a significant benefit on patient 
experience, with better communication and more culturally relevant 
information (Ahmed et al, 2015). 
The picture, which emerges from these studies, is of a diagnosis and 
treatment inequality for South Asian people across a range of chronic 
conditions. However, there had been no studies on whether this was true 
within gastroenterology and my research presented in this critical appraisal 
focused firstly on how and whether this was the case for gastrointestinal 
disease.  
Gastrointestinal Disease: 
Chronic gastrointestinal diseases requiring life-long therapy were 
increasingly recognised as major causes of significant morbidity from the 
1970s onwards. The scourge of peptic ulcer disease was brought under 
control by the introduction of cimetidine. So, for young and middle-aged 
people, ulcerative colitis, Crohn’s disease and coeliac disease are the main 
conditions within this group of chronic diseases. Achalasia is a progressive 
and debilitating disease of older people and, although uncommon, leads to 
multiple endoscopic and surgical interventions. 
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In parallel with the recognition that patients from BEM communities were 
experiencing sub-standard care, the traditional view that such chronic 
gastrointestinal diseases were uncommon in African and Asian BEM 
communities started to be questioned. This followed from studies in 
Birmingham (Benfield and Asquith, 1986) and Leicester (Jayanthi et al, 
1992, Probert et al, 1992). This belief had been largely based on the 
anecdotal work of Dennis Burkitt, who attributed any alleged lower 
incidence in both migrant South Asian and African communities living in 
East Africa to their high unrefined fibre intakes. (Burkitt, 1973 and 1979) 
As a consequence of such thinking, most clinicians considered chronic 
gastrointestinal diseases uncommon in South Asians and interpreted the 
classical signs of these conditions as due to infective causes, acquired 
during visits to East Africa, India, Pakistan or Bangladesh (Bandaranayake, 
1986). Little attention was, therefore, given to gastrointestinal disease in 
migrant populations in the UK. 
By the early 1990s, Crohn’s disease and ulcerative colitis were first 
recognised to be common amongst South Asian migrants in both Leicester 
(Jayanthi et al, 1992 i, Probert et al, 1992 i) and Tower Hamlets (Jayanthi et 
al, 1992 ii and Probert et al, 1992 ii). During the same period, the highest 
incidence of coeliac disease in the world was reported amongst Punjabis in 
Leicester (Sher et al, 1993). A study of colorectal cancer in Leicestershire, 
from 1981 to 1991, showed younger patients had a trend towards increased 
frequency (Gee and Mayberry, 2000). This finding was confirmed in a later 
study with South Asian patients presenting at a younger age, but they also 
had more advanced disease (Norwood et al, 2009).  Clearly, the burden of 
chronic gastrointestinal disease and colorectal cancer in the South Asian 
population in the UK was significant and studies had indicated that it was 
both increasing and affecting the younger generations.  
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With such significant changes, it was important to investigate whether there 
were any barriers of access to healthcare services or treatment, which could 
lead to poorer outcomes. The purpose of my research was firstly, to map out 
patterns of care for BEM communities, in particular the South Asian 
community. Subsequent to these studies, which demonstrated that there was 
widespread disparate care experienced by the South Asian community 
across a range of chronic gastrointestinal diseases over prolonged periods, 
my subsequent research considered responses from organisations tasked 
with ensuring equality within the NHS. This second focus of my research 
was on the role of structural racism in contributing to these disparities. 
Institutional or Structural Racism and its consequences: 
The events of the evening of 22 April 1993, when Stephen Lawrence, a 
Black teenager, was murdered, whilst waiting for a bus, in Eltham, London 
and the inadequate investigation by the Metropolitan Police, led to a public 
inquiry conducted by Sir William Macpherson. The report considered that 
police were institutionally racist. The concept was crystallised by 
Macpherson as: 
“The collective failure of an organisation to provide an appropriate 
and professional service to people because of their colour, culture, or 
ethnic origin. It can be seen or detected in processes, attitudes and 
behaviour which amount to discrimination through unwitting 
prejudice, ignorance, thoughtlessness and racist stereotyping which 
disadvantage minority ethnic people.” (Para. 6.34) (Macpherson, 
1999) 
Institutional or structural racism was recognised within the NHS shortly 
after publication of the Macpherson report (Collier, 1999). However, there 
has been little subsequent effective work done to limit its impact. Although 
discrimination against staff is frequently reported, that experienced by 
patients receives considerably less attention. Nevertheless, subsequent to 
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Macpherson (1999), the Public Sector Equality Duty (Equality Act (2010)) 
reflected changes in policy and formed the basis for the statement in the 
NHS Constitution that: 
“Legal duties require NHS England and each clinical commissioning 
group to have regard to the need to reduce inequalities in access to 
health services and the outcomes achieved for patients.” (emphasis 
added) (Department of Health, 2015) 
 
In 2013, NHS Monitor (later renamed NHS Improvement!) was tasked with 
issuing Provider Licences to Trusts and among the conditions is: 
 
“4 (b) reducing inequalities between persons with respect to their 
ability to access those services” (Monitor, 2013) 
 
Organisations, such as Trusts, Clinical Commissioning Groups and NHS 
Improvement, need to act in ways which are consistent with their ethos and 
the NHS Constitution for England of 2021 states: 
 
“It has a wider social duty to promote equality through the services it 
provides and to pay particular attention to groups or sections of 
society where improvements in health and life expectancy are not 
keeping pace with the rest of the population.”  
 
However, in 2019 the British Medical Journal published an editorial on the 
health experiences of BEM patients and related it to “decades of evidence 
of disparities in health outcomes related to ethnicity” (Kmietowicz et al, 
2019). It reported that: 
“The evidence is clear on the discrimination and prejudice against 
patients and staff from ethnic minorities. What is less clear is the 
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appetite of health systems in the UK and around the world to tackle 
age-old health inequalities based on race and ethnicity.” 
 
Indeed, there have been no reports of responsible organisations ever taking 
action on the basis of ethnic or religious discrimination. As Salway et al 
(2016) have pointed out, this is often due to managers and teams not 
considering that tackling ethnic healthcare inequities is part-and-parcel of 
their job. 
 
Current failures to take effective action have helped engender distrust in 
BEM communities, as reflected in poor uptake of the Covid-19 vaccination 
program (Robertson et al 2021). During the Covid-19 epidemic, Dr Raghib 
Ali, UK government advisor and epidemiologist, reinforced negative 
attitudes to structural racism within healthcare, when he said: 
 
"If structural racism was an important problem, not saying it doesn’t 
exist, but if it was an important problem in healthcare outcomes, 
you’d expect it to be reflected not just in Covid but with other 
outcomes as well." (Editorial, 2020) 
Similar views have been reiterated in the recent Report by the Commission 
on Race and Ethnic Disparities (2021), where the conclusion concerning 
health in BEM communities was: 
 “These factors are complex but this is no way an overall negative 
 picture for ethnic minority groups, and the Commission believes that 
 more should be done to learn from those ethnic minorities that have 
 better health outcomes despite being more deprived to improve health 
 for all ethnic groups, including White ethnic groups.” (p.213) 
Limited attention was given to the poorer outcomes for many diseases 
experienced by BEM communities, as summarised in the comment: 
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 “racism and discrimination are not widespread in the health system, 
 as is sometimes claimed” (p. 219) 
and consistent with the Chairman’s view that one chapter should have been 
entitled:  
‘The end of BAME (Black, Asian and minority ethnic)’ p. 9 
Changes Needed to Address Structural Racism: 
Understanding and effectively addressing how racism affects health is 
critical to improving population health and reducing ethnic inequities in 
health. The situation is even more pressing for elderly members of BEM 
communities (Burholt, Wenger and Shah, 2002). For example, the Race 
Disparity Audit (Cabinet Office, 2018 p.46) found Pakistani and 
Bangladeshi people over 65 years old had a particularly poor health-related 
quality of life. In order to achieve significant improvement, there will need 
to be policy changes directed at reforming institutional cultures, as well as 
tackling issues of social deprivation and racism (Chouhan and Nazroo, 
2020).   
 
As Williams, Lawrence and Davis (2019) have pointed out there is now a 
need to examine which structural processes are involved in the production 
and continuation of disparate care, including consideration of the role of 
immigration. This submission looks at the actors which control the patient 
experience in a systematic way from the clinical interface through to the 
regulatory bodies. Weaknesses in earlier studies included a failure to 
investigate differences in delivery of care over prolonged periods, 
confirmation of findings through checking the validity of data by using 
different methods of collection and using comparable approaches across 
different geographical areas. There were no investigations of management 




This critical appraisal assessed whether disparate care was an issue for 
patients with chronic gastrointestinal diseases. The initial study deals with 
the management of ulcerative colitis in a cohort of patients across a 10-year 
period. This leads on to a study of access to expensive biologic therapy for 
Crohn’s disease in the same Trust. Both studies demonstrated disparate care 
for South Asian patients. Access to biologic therapy was then assessed 
across a range of Trusts in England and the initial results confirmed. A 
subsequent study, about 5 years later, demonstrates that there has been no 
improvement and disparate care is also seen amongst other BEM 
communities. The situation with regards to a different chronic 
gastrointestinal disease, namely achalasia is examined. The incidence in 
South Asian people was determined for the first and only time. The reality 
of cancer risk in this condition is assessed by metanalysis. Then the forms 
of current treatment were examined across a range of trusts and South Asian 
patients are more likely to be exposed to new procedures, namely Per Oral 
Endoscopic Myotomy (POEM), as practitioners develop their skills. The 
attitudes of Trusts and other regulatory bodies are examined and the 
potential solutions considered in a detailed analysis of inquiries and judicial 
review. This critical appraisal also presents a collection of review papers 













2. Aims and description of the research programme: 
The overriding question addressed by this research programme was: 
“To determine the scale, nature and reasons for disparities of 
healthcare in England and Wales for South Asian minority patients 
with chronic gastrointestinal diseases, with some consideration of 
other BME communities.” 
Its main objectives were: 
1. To undertake systematic reviews of chronic gastrointestinal diseases 
in the South Asian communities in the United Kingdom and identify 
problematic areas in the delivery of healthcare and make comparison 
with the experience of other BEM communities 
2. To assess whether chronic gastrointestinal diseases, such as achalasia, 
had a comparable incidence in the South Asian community compared 
to the White British community and whether cancer risk is a 
significant issue. 
3. To establish whether there was evidence of disparate care to the 
South Asian community across England, using chronic 
gastrointestinal diseases as an exemplar and whether this was long 
term and/or related to high-cost therapies. 
4. To identify the response of various governmental agencies to 
evidence of disparate care and available legal solutions. 
In order to achieve these objectives, the research programme was divided 
into four stages, which were: 
1. Reviews to establish the relative incidence of major gastrointestinal 
diseases in the South Asian population and, therefore, the need to consider 
whether they are receiving equal treatment: 
The published reviews presented in this dissertation considered studies on 
the incidence of inflammatory bowel disease, coeliac disease, oral disease 
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and colorectal cancer among South Asian patients. Within these reviews, 
issues related to access to diagnosis and therapy were investigated and the 
effectiveness of various solutions assessed. In addition, attitudes to national 
screening and surveillance programs for prevention and early detection of 
premalignant or early malignancy were separately reviewed and the reasons 
for disparate uptake considered. The issues identified in this latter review 
have direct relevance in day-to-day clinical management decisions. 
2. Studies to determine the incidence of achalasia in the South Asian 
community, assess the long-term cancer risk of this condition and examine 
patterns of care. 
Earlier studies conducted in Leicester defined the incidence of 
inflammatory bowel disease as higher in South Asians compared to the 
White community(Jayanthi et al. i, 1992; Probert et al. i, 1992.However, 
there were no data on the incidence of achalasia in the South Asian 
community in Leicester or, indeed, anywhere in the world. In addition, there 
had been no definitive study to determine cancer incidence in this condition. 
Its particular relevance to studies on disparate care lay in the fact that this is 
a condition which is commonest among the older sections of society. The 
review of issues concerned with delivery of care had determined that the 
elderly experience particular difficulties in this area (Mayberry and Farrukh, 
2012). 
3. Studies of the treatment of inflammatory bowel disease and disparity of 
care 
These studies were organised so as to investigate firstly whether there was 
evidence of disparate care in the management South Asian patients with 
chronic gastrointestinal disorder, namely ulcerative colitis in Leicester and 
Leicestershire. The approach adopted was to follow a cohort of patients 
diagnosed with ulcerative colitis over a period of a decade and compare 
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management decisions made during that time by review of their individual 
records. This was and is the only study to adopt such an approach. 
The second study investigated the provision of expensive biologic therapy 
to patients with a different chronic gastrointestinal disorder, namely 
Crohn’s disease in Leicester and Leicestershire. This study was based on an 
analysis of the records of all patients entered into the treatment register for 
this condition. 
The third study investigated whether disparate care in the delivery of 
biologic therapy was widespread across Trusts which served substantial 
South Asian populations. It used a Freedom of Information (FOI) approach 
to obtain these data. As part of the study, data was collected from Leicester 
to allow direct comparison with that obtained by review of individual 
clinical records in the previous study. This allowed validation of data 
obtained by an FOI. 
The fourth study again used an FOI approach to assess whether disparate 
care was seen amongst other BEM populations, namely Afro-Caribbean and 
Eastern European. Validation of the data obtained on this occasion was 
confirmed through inclusion of two trusts with significant South Asian 
populations, where disparate care was again seen. 
4. Follow-up studies of response in NHS trusts: 
A study of the responses by NHS trusts, Health and Well-being Boards and 
Clinical Commissioning Groups, where there was evidence of disparate 
care for patients with inflammatory bowel disease from the South Asian 
community was conducted one year after they were informed of the issue. 
In addition, similar questions were put to the Care Quality Commission, 
NHS Improvement and the Equality and Human Rights Commission, which 
are the bodies with statutory responsibility for ensuring equitable delivery 
of care. Responses were analysed using a themes analysis. 
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As a result of the lack of action by these bodies, a detailed review of the 
legal options available to BEM communities to deal with disparate care was 
undertaken. This included an assessment of the role of Royal Commissions, 
statutory and non-statutory inquiries and judicial review. 
In the subsequent chapter, a critical review of the submitted papers is 
presented. The papers will be grouped together under three separate 
headings: 
1. Original studies on the provision of care to minority communities 
with chronic inflammatory bowel disease. 
2. Original studies in achalasia. 
3. Studies of managerial responses and legal solutions. 
4. Review. 















3. An Analysis of Published Papers 
Original studies on the provision of care to minority communities with 
chronic inflammatory bowel disease: 
The following papers provide an original analysis of the care of minority 
communities in England with Crohn’s disease and ulcerative colitis. The 
studies were conducted using different methods in different populations at 
different times and so through triangulation confirm that disparate care is 
widespread and significant. 
They are largely presented in the chronological sequence in which the 
research programme developed, although due to variations in time to 
publication, this is not necessarily reflected in the date of the paper.  
 
Farrukh, A. and Mayberry, J. (2016) 
‘Patients with ulcerative colitis from diverse populations: the Leicester 
Experience.’ 
Medico Legal Journal  84(1), pp. 31 – 35 
 
This original study was the first study to consider disparities in the delivery 
of care to patients with ulcerative colitis of South Asian origin over a 10-
year period. It remains unique and demonstrated that South Asian patients 
were significantly less likely to see a consultant and more likely to be 
discharged. Although admitted to hospital more often, South Asian patients 
underwent fewer investigations and were less likely to be in a surveillance 
program for detection of colorectal cancer.  
 
The strengths of this study include the requirement that all patients had been 
newly diagnosed, with histological evidence of ulcerative colitis, in order to 
be eligible for inclusion. This cohort of candidate patients was then 
reviewed to ensure that they had been resident within the defined catchment 
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area around Leicester for the same decade and so had received treatment 
within the same NHS trust.  
 
The clinical records of all candidate patients were reviewed by one of two 
researchers and a standard pro forma completed. A sample of records were 
checked for similarities in scoring. There was no significant discrepancy, 
but data for this correspondence across scorers was not included in the 
published report. It would have added to the strength of the results section, 
if this had been the case. 
 
The siting of the study in Leicester also gave added strength as it is one of 
the few cities in England where there have been detailed earlier 
epidemiological studies of inflammatory bowel disease. In addition, the city 
has one of the largest South Asian communities in the UK, comprising 
almost half of its total population. So, there was a clear potential for a 
robust investigation of disparate care, because of significant numbers of 
patients with ulcerative colitis from both communities. Confirmation of the 
strength of this study comes from the similar mortality of this cohort to that 
in a previous study, conducted a decade earlier (Probert et al, 1993). This 
similarity gives further support to the accuracy of the findings of disparate 
day-to-day care. 
 
The fact that the study was conducted a decade after the cohort of patients 
was identified, rather than from the beginning, gives added strength to the 
study. It shows what clinicians did in real life rather than if they knew they 
were under observation. 
 
A limitation of the study was the fact that 109 of 372 candidate cases had 
been destroyed, were incomplete or could not be traced. However, as 76% 
of the 263 candidate cases were rejected as not meeting the criteria for 
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inclusion in the study, it is possible that of the 109 lost files 26 cases may 
have been eligible. However, this assumption has underlying weaknesses 
as, in general, case notes of patients with active inflammatory bowel disease 
are seldom lost or destroyed, because of their need for on-going care. 
 
As a consequence of this study, which had indicated South Asian patients 
with ulcerative colitis were less likely to receive detailed care, a separate 
study of access to expensive treatment was undertaken. 
 
Farrukh, A. and Mayberry, J. (2015) 
‘Apparent discrimination in the provision of biologic therapy to patients 
with Crohn's Disease according to ethnicity.’ 
Public Health 129 (5),  pp. 460 - 464  
 
This original study is again the first study to consider disparities in the 
delivery of care to patients of South Asian origin, but on this occasion, with 
Crohn’s disease. It was based in Leicester and again required review of 
individual cases and their records. 
 
Its purpose was to investigate whether disparate care was seen in a different 
condition to ulcerative colitis, although with similar clinical characteristics, 
and to specifically consider expensive treatment, in the form of biologic 
therapy. On this occasion, the study was conducted retrospectively and was 
based on a register of patients who have received either infliximab or 
adalimumab, over a four-year period. Of the 139 patients, who received 
such treatment, only 13 were South Asian. The expected number of South 
Asian patients ranged between 33 and 52, depending upon the approach 
adopted to make the estimate. The number of South Asian patients who 





A major strength of this study is the centralised register for all patients with 
inflammatory bowel disease receiving this therapy. The register is kept 
scrupulously, because of the cost of the therapy. A further strength of the 
study is the detailed information available on the epidemiology of Crohn’s 
disease in Leicester and of the population structure of the city. However, 
one limitation to the epidemiological data is that the measure for prevalence 
of the disease was from the 1990s and it seems probable that by 2010 this 
figure was an underestimate for both communities. The main limitation to 
the study was that it could not provide any data on patients who had been 
offered biologic therapy, but chose not to have it. From recent work on the 
uptake of vaccination against Covid 19 by the South Asian community, it is 
possible that there may have been a reluctance to accept biologic therapy. It 
is possible that this could have been a contributory factor to the clear 
disparity between the South Asian and White British communities, but this 
will be addressed in a subsequent study, where uptake by Eastern European 
migrants was investigated. 
 
The question which arose from this study was whether disparate care for 
both ulcerative colitis and Crohn’s disease was confined to the Leicester 
area or was seen elsewhere within England. The subsequent study addressed 
this question. 
 
Farrukh A & Mayberry J (2015)                                      
‘Ethnic variations in the provision of biologic therapy for Crohn’s 
Disease: A Freedom of Information Study.’                                                                        
Medico-Legal Journal  83(2),  pp. 104 – 108 
 
This study identified three NHS trusts which provided disparate care to 
their South Asian and white British patients with Crohn’s disease. In 
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Pennine Acute Hospitals NHS Trust, covering Oldham and North 
Manchester, Barking, Havering & Redbridge University Hospitals NHS 
Trust and University Hospitals of Leicester NHS Trust significantly lower 
than expected numbers of South Asian patients received treatment with 
biologic therapy. This contrasted with six other trusts with significant ethnic 
minority communities where there was no evidence of disparate care. 
 
This study used a different methodology to identify patients and a major 
strength was its confirmation of discriminatory care that had previously 
been demonstrated at University Hospitals of Leicester NHS Trust. The 
original study had used a register of patients, with review of their clinical 
records. This study utilised Freedom of Information requests and so was 
based on an analysis of computer records of clinic attendances held by each 
of the trusts. Although the number of cases in Leicester differed between 
the two studies, the proportion, who were from the South Asian community, 
was the same, giving confidence to the result that there is evidence of 
disparate care, as demonstrated by less ready access to biologic therapy. 
 
The main weakness of the study is that there was no independent 
confirmation of the accuracy of the difference in treatment patterns at 
Pennine Acute Hospitals NHS trust or at Barking, Havering & Redbridge 
University Hospitals NHS Trust. The collection of data depended upon the 
approach taken by the hospital staff and there can be no certainty that 
similar techniques for searching the databases were used at the different 
trusts. However, this study was not a comparison between trusts but rather 
what happened within a trust. 
 
This study demonstrated that discrimination in the provision of appropriate 
medical care to the South Asian community occurred outside of 
Leicestershire, but was not seen in every trust studied. The questions arising 
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from these studies included whether such disparate care was seen in other 
minority communities and whether, with time and greater awareness, this 
became less. The next study investigated these issues. 
 
Farrukh, A. and Mayberry, J.F. (2020)                                                                           
‘Apparent disparities in hospital admission and biologic use in the 
management of inflammatory bowel disease between 2014 – 2018 in some 
Black and Ethnic Minority (BEM) populations in England.’                                                   
Gastrointestinal Disorders 2(2), pp. 141 – 151 
This study used Freedom of Information methodology to investigate 
provision of biologic therapy in the management of inflammatory bowel 
disease in trusts with significant Afro-Caribbean and Eastern European 
communities. As a comparator, two trusts with significant South Asian 
communities, but which had not been previously studied, were also 
included. 
In Bristol, Nottingham, Derby and Burton, Princess Alexandra Hospital 
Trust in Harlow, Essex and Kings College Hospital NHS Foundation Trust 
in South London, Afro-Caribbean patients were treated significantly less 
often than White British patients. Eastern European migrant workers, were 
admitted significantly less often in Croydon and the Princess Alexandra 
Hospital NHS Trust in Essex. In both North West Anglia and Princess 
Alexandra Hospital South Asian patients were significantly less likely to 
receive biologic therapy than White British patients. Clearly, Afro-
Caribbean patients with inflammatory bowel disease experienced the same 
level of discrimination as seen in South Asian communities. The recent 
experience with Covid 19 vaccination raised the possibility that one 
explanation could be a reluctance to utilise modern therapeutic 
interventions. However, similar disparate care was seen in the management 
of people of Eastern European origin, who had inflammatory bowel disease. 
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There is no published evidence to suggest that Eastern European patients 
have a different view about biologic therapy than Western European 
patients; so lack of access to biologic therapy in minority communities 
seems widespread and to transcend cultural differences. 
 
The strengths of this study include the consistent finding that University 
Hospitals of Birmingham NHS Trust showed no evidence of discrimination 
against Afro-Caribbean patients compared to White British patients, as it 
had not in the case of South Asian patients with Crohn’s disease, as shown 
in the 2015 study. However, trusts with significant South Asian 
populations, such as in Peterborough and Harlow, had comparable findings 
to those reported earlier from Leicester, Havering and Redbridge and Acute 
Pennine Trust, covering Oldham and North Manchester, which had shown 
disparate care in the prescription of biologic therapy in the 2015 test. 
 
The main weakness in this study concerned data on the population served 
by the trusts. In general, they were unable to provide an ethnic breakdown 
and reliance was placed on population data from the conurbation in which 
the trust was situated. However, the area served by a trust does not 
correspond with political boundaries, within which population data are 
collected. Data on the prevalence of inflammatory bowel disease in the 
Afro-Caribbean community is severely limited, with the only realistic 
estimates coming from Derby, and this means that, together with the 
population data issue, the expected number of cases may be inaccurate. 
Nevertheless, the magnitude of difference in provision of biologic therapy 
was extremely large in some trusts with statistical significance at a level of 
p < 0.00001. 
 
This study was conducted later than previous studies and has shown no 
improvement in access to biologic therapy. In addition, there is clear 
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evidence that patients from Afro-Caribbean and Eastern European 
communities are just as unlikely to receive appropriate treatment as is the 
case of South Asians. These studies have been concerned with chronic 
inflammatory bowel disease. The next step was to consider a different 
chronic gastrointestinal disease.  
 
Ideally, such a disease would be of comparable incidence in white British 
and South Asian communities and would affect older sections of society, 
which are often poorly represented in cohorts of patients with inflammatory 
bowel disease. In addition, it was considered desirable that disease should 
also carry a significant cancer risk, as in the case of both Crohn’s disease 
and ulcerative colitis. The disease selected was achalasia. 
 
Original studies in achalasia: 
 
Although there have been a considerable number of studies on the incidence 
and prevalence of achalasia in the UK, there were none of which 
specifically looked at its frequency in the South Asian community. 
Therefore, prior to investigating patterns of care in achalasia, it was first 
necessary to assess its incidence in the South Asian community and also to 
confirm the reality of any association with later development of cancer. 
 
Farrukh, A., De Caestecker, J. and Mayberry, J.F. (2008)                            
‘An epidemiological study of achalasia among the South Asian 
population of Leicester, 1986-2005.’                                                                                                
Dysphagia  23(2), pp. 161- 4 
This original study was the first study of the incidence of achalasia in the 
South Asian population, anywhere in the world. It remains the only such 
study in which case was distinguished from non-case through a review of 
original case records and investigation. The overall incidence was 0.89 
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cases/105/year, with a figure of 1.79 cases/105/year (95% confidence 
interval 0.7–3.7) in the last quinquennium of the study. 
 
The strength of this study lies in its use of a clear definition of achalasia 
prior to a review of individual patient’s clinical records. A cohort of 
candidate cases was identified from four separate sources, namely hospital 
activities analysis, endoscopy records, manometry records and pharmacy 
records related to prescription of botulinum toxin. A further strength was in 
restriction of the study to residents of the city of Leicester, for which 
detailed population analysis was available. 
 
The main weakness of the study lies in the absence of a contemporaneous 
study of the incidence of achalasia in the White British population of the 
city. However, earlier studies at various times during the last 50 years have 
shown that the incidence of achalasia in the UK has been fairly stable at 
about 0.8/105/year. 
 
The incidence of the disease climbs steeply after the age of 50, with a peak 
at 17/105/year in those aged 80 or older. Achalasia met the criteria that were 
desirable for a suitable candidate as the second chronic gastrointestinal 
disease to be investigated. The following study addresses the issue of cancer 
risk in achalasia. 
 
Gillies, C.L., Farrukh, A., Abrams, K.R. and Mayberry, J.F. (2019)                                 
‘Risk of esophageal cancer in achalasia cardia: A meta-analysis.’                          
JGH Open 3(3), pp196 – 200 
This was the first meta-analysis of 16 studies drawn from a pool of 27 
studies on the occurrence of oesophageal cancer in patients with achalasia 
identified over a period of 50 years. The analysis was stratified between 
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cancers identified in the first year after diagnosis of achalasia and cancers 
identified in subsequent years. The incidence rate of oesophageal cancer in 
achalasia patients was estimated to be 1.36 (95% CI: 0.56, 2.51) per 1000 
person years, which is over 10 times higher than the general population 
incidence rate.  
 
The main strength of the study was its size in that it involved 4389 patients, 
identified from reports across the world, with 73 cases of oesophageal 
cancer. By stratifying the cancer risk the effect of an oesophageal cancer 
mimicking achalasia in its presentation was eliminated. 
 
Weaknesses of the study included its 50-year time span, so involving 
studies when endoscopy was not commonly performed, resulting in 
possibly less frequent identification of cancer. It was also decided to include 
two studies from South America where Chagas disease can cause a 
megaoesophagus. However, of the 343 patients from Chile and Argentina 
only 17 tested positive for Chagas disease. Whether any of the 11 patients 
who developed oesophageal cancer had Chagas disease was not reported. 
The proportion of patients developing cancer in South America (3.2%) was 
significantly greater than elsewhere (1.5%) (z = 2.32, p <0.02). 
 
This study confirmed that achalasia is a significant risk factor for 
development of cancer in the affected organ, so strengthening the rational 
for its use as a comparator to inflammatory bowel disease. The subsequent 
paper investigated the pattern of management experienced by patients with 






Farrukh, A. and Mayberry, J.F. (2021)                                                                               
‘Original observational study on disparate treatments for achalasia 
experienced by patients of white British and South Asian ethnicity.’                                                   
Annals of Esophagus  doi: 10.21037/aoe-20-72: 
http://dx.doi.org/10.21037/aoe-20-72 
This was the first study to consider whether there was disparate care related 
to ethnicity in the management of patients with achalasia. Patients were 
identified through Freedom of Information requests to 13 trusts with 
significant South Asian communities. South Asian patients received a 
different pattern of treatment to their White British counterparts and were 
significantly more likely to have a POEM procedure in inexperienced 
centres. The study also demonstrated that different patterns of treatment 
were not linked to levels of social deprivation. 
The strength of this study is demonstrated by the close correspondence 
between the number of cases for Sandwell and Birmingham obtained 
through the freedom of information request and those in a study by different 
authors using a different method based on nationally coded data from 
Hospital Episode Statistics and The Health Improvement Network (Harvey 
et al 2019). 
The main weakness in the study is that no sample of notes was checked for 
accuracy the diagnosis. However, Freedom of Information requests only 
generate anonymized data and so from conception, such a check could not 
be incorporated into the search protocol. It is of note that despite data being 
anonymized, six of the 13 trusts declined to provide specific figures on the 
fallacious basis that this would allow identification of patients. When a 
further analysis, using the ranges provided by these six trusts, was 




This study has demonstrated that patients from ethnic minorities in the UK 
with a different chronic gastrointestinal disease experience different care to 
their white British counterparts and this includes greater exposure to new 
treatments in the hands of inexperienced clinicians. 
Arising out of these studies is the question of what has been the attitude of 
responsible bodies, such as NHS trusts, clinical commissioning groups and 
other national organisations, such as the Care Quality commission and the 
Equality and Human Rights Commission. This question is addressed in the 
following study. 
Studies of managerial responses and legal solutions: 
Farrukh, A. and Mayberry, J.F. (2019)                                                                     
‘Does the failure to provide equitable access to treatment lead to action by 
NHS organisations? The case of biologics for South Asians with 
inflammatory bowel disease.’                                                                                                                              
Denning Law Journal  31,  pp. 77 – 91 
This is the first and only study to collect data on the response to disparate 
care by organisations responsible for ensuring equality of healthcare 
delivery. It is based around the three trusts identified in the initial 
multicentre study of biologic therapy in Crohn’s disease. Neither NHS 
trusts, Clinical Commissioning Groups nor Health and Welfare Boards took 
any action in response to their discriminatory practice in the year 
subsequent to the study by Farrukh and Mayberry (2015 ii). The Care 
Quality Commission and NHS Improvement denied statutory responsibility 
for such issues and the Equality and Human Rights Commission had never 
investigated any cases of such discrimination nationwide. 
The strength of this study is based on its use of data provided by the trusts 
themselves. In addition to the responses by the trusts, confirmation was 
obtained from local and national monitoring bodies that no action had been 
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taken with regards to discrimination in the delivery of care. Responses were 
provided from departments within the organisations, which were 
responsible for public liaison. 
The study could have been improved by direct discussions with Equality 
and Diversity officers within the responsible trusts, but such assessments 
are unlikely to have been allowed in the context of the official responses. 
At a local level, there is little prospect of trusts which exhibit disparate care 
changing their stance and so the question arises as to what legal remedies 
are open to BEM communities. These possibilities are considered in the 
following study. 
Farrukh, A. (2020)                                                                                                   
‘What are the legal mechanisms for seeking solutions to disparities in 
the delivery of care in the NHS and where does liability lie?’                                      
Denning Law Journal 32,  pp. 51 - 86  
This comprehensive review considered the potential role and effectiveness 
of Royal Commissions, statutory and non-statutory enquiries and judicial 
review as possible methods for dealing with the issue of disparate care to 
BEM communities. Its conclusion was that, at present, the only solution lay 
with individual actions for substandard care, resulting in poorer outcomes, 
through the tort of negligence. 
The strength of this study lay in the wide-ranging review of the role of 
commissions and enquiries, specifically related to the NHS and 
consideration of the scope of judicial review. Its weakness lies in the fact 
that, as to date, none of these bodies have considered disparate care for 
ethnic minorities. 
Reviews: 
Throughout the duration of the original studies on disparate care, published 
work on the experience of people of South Asian origin, in utilising 
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healthcare services in the UK, was collected and this resulted in a series of 
reviews related to the original research and wider issues. The review papers 
emerged from background studies to the research program and do not relate 
directly to its chronological order. 
Mayberry, J.F. and Farrukh, A. (2012) 
‘Gastroenterology and the provision of care to Panjabi patients in the 
UK.’ 
Frontline Gastroenterology 3(3), pp. 191 – 198 
 
Farrukh, A., Sayeed, S. and Mayberry, J.F. (2014) 
‘Oral health and the provision of care to Panjabi patients in the UK.’ 
Dental Update  41(7),  pp. 629 – 636 
 
Farrukh, A. and Mayberry, J.F. (2019) 
‘Inflammatory bowel disease and the South Asian diaspora.’                              
JGH Open 3(5),  pp. 358 – 360 
 
Farrukh, A. and Mayberry, J.F. (2019) 
‘Evidences of differences and discrimination in the delivery of care: 
colorectal screening in healthy people and in the care and surveillance of 
patients with inflammatory bowel disease.’                
Gastrointestinal Disorders 1(2),  pp. 253 – 260 
 
These reviews summarise the known epidemiology of various 
gastrointestinal diseases in the South Asian communities in the UK. They 
also drew attention to issues experienced with use of services and accessing 
appropriate translators and provision of information in appropriate 
languages. The main weaknesses identified through these reviews are the 
failure to address issues of discrimination, delivery of care according to 
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Three chronic gastrointestinal diseases, namely ulcerative colitis, Crohn’s 
disease and achalasia, were chosen as exemplars of conditions which 
require long-term clinical management involving both primary and 
secondary care sectors. Achalasia acted as a useful contrast in that it 
predominantly affects older people and effective treatment requires 
surgical-type interventions rather than ongoing medical treatment. 
The main findings in the nine studies presented in this dissertation were: 
a. Patients with chronic ulcerative colitis from South Asian minority 
communities in Leicester were seen significantly less often by 
consultants, underwent fewer investigations and were discharged 
significantly more than White British patients over a decade. 
b. South Asian patients with Crohn’s disease are less likely to have 
equitable access to expensive treatments, namely biologic therapies, 
in Leicester and other NHS trusts in England. Patients with chronic 
inflammatory bowel disease from Afro-Caribbean and Eastern 
European minority communities also experience poorer access to 
expensive biologic therapies. 
c. Chronic gastrointestinal disease, in the form of achalasia, is, at least, 
as common in the older South Asian community as in White British 
people. In all communities there is a significant increased risk of 
oesophageal cancer in the years following diagnosis. 
d. South Asian patients with achalasia are more likely to be offered a 
new form of treatment, whilst practitioners are developing their skill, 
than White British patients. 
e. NHS organisations and national bodies charged with ensuring 




f. Effective legal mechanisms by which minority communities can seek 
redress are limited and, currently, individual action based on the tort 
of negligence is the only route open to patients who have experienced 
poorer care. 
The studies presented have systematically considered standard treatments 
provided over a period of a decade as well as access to expensive 
treatments. In addition, they examined the nature of treatments offered to 
patients and identified, for the first time, the fact that elderly South Asian 
patients were disproportionately represented on the learning curve of 
endoscopists offering a new treatment, namely POEM. The studies have 
demonstrated evidence of widespread, persistent and disparate care in the 
management of BEM patients with chronic disease. 
Data in these studies were drawn from a variety of sources. These included 
pathology, endoscopy and radiology records, as well as a patient register. In 
the studies using these techniques, the diagnosis and patients’ ethnicity 
could be confirmed directly. In other studies, particularly those based on 
Freedom of Information data, the accuracy of the diagnosis, treatment 
provided and patient ethnicity depended upon coding by hospital clerical 
staff and, subsequently, on Freedom of Information Officers applying the 
correct search terms to Trust’s databases, such as Hospital Episode 
Statistics. Inaccurate coding by clerical staff and lack of motivation or 
interest on the part of Information Officers are recognised sources of 
significant potential errors.  
Although such data are collected to better inform NHS and government 
policy, data provided under Freedom of Information requests were 
anonymised, so preventing any sampling to check on their accuracy. These 
data counted episodes and may not have directly correlated with individual 
cases. However, they did measure differences within Trusts, as in the 
Leicester studies, where the proportion of patients receiving different 
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biologic treatments and the male to female ratio were the same, whether 
assessed by individual cases or by episodes. This comparison lends support 
to the reality of the disparate care. In the Freedom of Information studies of 
inflammatory bowel disease, comparisons were not made across Trusts, but 
only within Trusts. In this way, the effect of differences in coding practice 
or motivation of officers in different trusts was eliminated.  
Data on ethnicity were sourced from relevant local government 
departments. There are limitations to such data, which include: Trust and 
Local Authority boundaries not being co-terminous, ethnicity being self-
defined and migrant transient working populations varying with time. 
However, there are no other independent sources to confirm these 
government generated data.   
In direct observational studies, based on known patients, variability in the 
quality of the data collected was minimised by a second observer checking 
sample data collection sheets. However, in Freedom of Information studies, 
an error in coding could be further amplified by poor search questioning of 
the data base by the officer. The restriction of comparisons within 
individual trusts ensured that such errors were constant across the ethnic 
groups within that trust. It is perhaps one of the most striking aspects of 
these studies that, even with such limitations on the data, the differences in 
care experienced by various BEM communities are so large. 
The unique nature of this collection of papers is their bringing together 
evidence of widespread disparate care within one medical discipline 
covering prolonged periods, different geographical areas and different 
diseases. It has also demonstrated institutional inertia, indeed, indifference 
to clear evidence of disparate care, with no organisation prepared to take 
responsibility, despite statutory requirements that they should. 
The research presented in this dissertation is a unique and make a 
substantial contribution to a much wider discussion about access to health 
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care by South Asian communities in the United Kingdom. It aligns with 
previous isolated studies, which have shown evidence of disparate care for 
certain aspects of various diseases, in a range of communities. The studies 
presented here demonstrate widespread disparate care for several chronic 
gastrointestinal conditions across England over prolonged periods, 
indicating the depth and seriousness of the issue. 
My studies reinforce findings from reports of treatments for coronary artery 
disease in Leicester (Lear et al i and ii, 1994), Newham (Wilkinson et al, 
1996) and Birmingham (Kendall et al, 2012), which demonstrated poorer 
care for South Asian patients. This included limited access to expensive 
treatment in cardiology (Mistry et al, 2020). However, such studies were 
usually isolated and snapshots in time. The longest ongoing study was in 
diabetes and covered a period of only one year. (Kendrick and David, 
2004). The only study which considered the disparate types of treatments 
received by different communities was in breast cancer management, where 
Pakistani women were less likely to be offered radiotherapy or hormone 
treatment than White women (Jack, Davies and Møller, 2009).  
The findings in this dissertation have shown that there are clear differences 
in the pathways of access to care for chronic gastrointestinal diseases for 
minority groups compared to the White British population. However, Black 
and Ethnic Minority (BEM) populations have long been blamed as the 
cause of their own ill-health (Donovan, 1986). For example, following a 
meeting of the Royal Society of Medicine in 1964, Patterson suggested that 
issues of poor child health in migrant communities was down to parental 
ignorance and that this could be remedied through appropriate and 
continuous education. In her paper, she wrote: 
“I would like to emphasize that the medical services have specific 
tasks in ensuring that no coloured children are deprived of medical 
care through ignorance, that their basic needs are met by continuous 
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health education and that those who work with coloured immigrants 
should be trained to understand their problems and to communicate 
with them.” 
These findings bring to mind comparable issues which were identified by 
the MacPherson Inquiry, which labelled such attitudes as “institutional 
racism”. In recent times, there has been a tendency to dilute the impact of 
this term through use of an alternative, namely “structural racism”. 
Structural, or institutional, racism encompasses social forces, institutions, 
ideologies, and processes which interact and create and reinforce 
inequalities (Powell 2008).  
Structural racism can be expressed in subtle ways. In the USA, for example, 
Hall et al (2015) have shown that most healthcare providers have a positive 
bias in favour of White patients and there is also evidence that physicians, 
who treat a disproportionate share of Black patients, have less training and 
less access to important clinical resources (Bach et al, 2004). In the UK, 
language discord between patients and their general practitioners has been 
shown to cause less satisfaction with communication (Brodie et al, 2016). 
Research on the nature of barriers, which limit access by BEM patients to 
healthcare, tends to attribute roles to language issues (Barron et al, 2010), 
lack of health literacy, (Rowlands et al, 2015), cultural problems (Alexaxis 
et al, 2015) and an inability to engage with the services provided 
(McFadden et al, 2018). In 2008, the Department of Health had recognised 
that a complex matrix of issues played a significant part in preventing 
effective communication between BEM patients and their general 
practitioners. These included: 
• Dysfunctional communication between health care organisations and 
patients. 
• Lack of choice and voice. 
• Community understanding of the healthcare system.  
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• Inflexibility in the system. 
• Continuity of care and the patient-doctor relationship. 
• Poor NHS links with local communities. (Lakhani, 2008) 
However, many managers and teams do not consider tackling ethnic 
healthcare inequities as part-and-parcel of their job (Salway et al, 2016). 
Indeed in 2021, the Commission on Race and Ethnic Disparities stated: 
“The Commission’s view is that individuals and communities of all 
ethnicities should be encouraged to take control of their own health. 
This would be both in relation to changing their own behaviours and 
in taking part in research studies to see what is effective.” (p. 228) 
There is a recent tendency to adopt the stance referred to by John Calmore, 
when he said: "Social injustices are now seen as natural misfortunes" 
(Marshall, 2004). Such natural misfortunes may be linked to education, 
income, diet and housing; whilst failing to recognise the role racism has 
played.  
Viewed within the context of racism, the findings of the studies summarised 
in this report raise questions as to why BEM patients should travel down 
different health care pathways to the White British community and to the 
role played by healthcare professionals in those decisions. Most 
disturbingly, there is a clear lack of appetite to address these issues, with 
open denial of their existence by trusts, which had provided the data 
(Farrukh and Mayberry, 2019 i). These concerns are heightened by the fact 
that those institutions, with statutory obligations to ensure equitable 
delivery of care, seem unaware of this role and have never taken any 
relevant action to implement change (Farrukh and Mayberry, 2019 i). This 
research does not provide an explanation for this institutional inertia. It is 
open to speculation as to whether a challenge through judicial review might 
be the necessary stimulus to encourage bodies, such as the Care Quality 
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Commission, NHS Improvement or the Equality and Human Rights 
Commission, to fulfil their statutory duties (Farrukh 2020). 
Issues of disparate care should be important to NHS trusts and other related 
organisations. This body of research makes it abundantly clear that little or 
no improvement has been seen in these areas, despite the CLEAR Action 
Plan of: 
 “Commission equitably for a diverse population  
 Leadership: ramp up the profile of the issues in local health 
 economies and identify leaders who will make it happen  
Engage, enable and empower citizens through literacy and shared 
 decision-making. Be on the side of’ patients and agree rights 
 and responsibilities  
Advance the quality of care through practice accreditation and robust 
 GP appraisal  
Record ethnicity data and monitor progress towards equality and 
 quality of care.” (Lakhani, 2008) 
This program emerged out of a review commissioned by the then Secretary 
of State for Health, Alan Johnson, as to why BEM communities found it 
more difficult to access general practice services than white patients. 
Despite being an official document of the Department of Health, the 
response on page 2 states: 
 “Action required N/A” (N/A = Not Applicable) 
and its purpose was: 
 “For information” 
The integration of issues of equality of care into the NHS Constitution and 
the provision of Provider Licences to trusts by NHS Improvement has not 
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translated into action on disparate care. To overcome institutional inertia 
there needs to be a local initiative and significant work by committed 
individuals within that trust, as demonstrated by the work of Cowan and 
Woodger (2006) in South London. However, there has not been long-term 
follow-up to assess whether the beneficial impact of small working groups 
on institutional racism is maintained. It does, however, lend support to the 
concept that institutions are made up of individuals and it is those 
individuals that formulate its policies in practice. Indeed, the long-term 
study on care of patients with ulcerative colitis in Leicester raised “the 
possibility that some senior doctors discriminated against South Asian 
patients and chose never to see them.” (Farrukh & Mayberry, 2016). Further 
support for such a proposition comes from the fact that there were a limited 
number of Trusts where there was no evidence of disparate care (Farrukh 
and Mayberry 2015 ii). 
 
The other aspect which this research has shown is the failure of current 
statutes and statutory instruments to have any impact on trusts and related 
organisations, which fail to meet their legal obligation to ensure equitable 
delivery of care (Farrukh and Mayberry, 2019 i). There is no effective 
monitoring and no penalties have been imposed on these organisations for 
these failures. Managers are not being held accountable for these 
deficiencies in their services. At present, judicial review and legal actions 
based on the tort of negligence provide the only possible remedy for 
disadvantaged patients and patient groups. To date, neither approach has 
been utilised in connection with disparate delivery of care (Farrukh, 2020). 
Clearly, there is a need for an easily accessible and open legal framework 
through which patients from minority communities can raise such issues 
without facing the significant expense associated with judicial review. In 
practice, this is likely to require recognition of earlier failures, new 
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legislation and restructuring of organisations with clear definitions of their 
tasks, with appropriate external monitoring. 
 
This research has exposed how little is known about why people with 
chronic gastrointestinal disease make decisions about their treatment and, 
more particularly, the role of cultural factors in those decisions. One 
significant component is the nature of barriers in access to care and linked 
with this is the role of practitioners in guiding patients down a particular 
healthcare pathway. The complexity behind such decisions can be seen in a 
theoretical study of the choices made by patients with Crohn’s disease, in 
relation to the ability of a surgeon (Harris and Mayberry, 2014). It is only 
through a better knowledge of such issues that remedial action can be taken, 
so as to improve the overall care of BEM patients with chronic diseases. 
Applicable techniques will need to include qualitative interviews and 
observations amongst both practitioners, patients and family members. A 
different approach would be to adopt Latour and Woolgar’s (1979) 
technique of investigating the daily activity of working scientists, as in 
Laboratory Life. This could be applied to hospital doctors and so help 
clarify how decisions are reached. Through such an insight it may be 












The studies presented demonstrate clear evidence of disparate care received 
by patients from ethnic minorities, including access to expensive therapies, 
greater exposure to new interventional techniques on the early part of 
operators’ learning curve, and for periods of up to 10 years in established 
care programs. These differences in standards of care are seen across three 
different chronic gastrointestinal diseases, namely ulcerative colitis, 
Crohn’s disease and achalasia. They are widespread across trusts, which 
serve minority communities, and affect South Asians, and as recently 
demonstrated, Afro-Caribbeans and Eastern Europeans as well (Farrukh and 
Mayberry, 2020). Despite the fact that statutes and statutory instruments 
require equality of care to be monitored, those national organisations 
charged with this responsibility have failed to institute any action related to 
patient ethnicity. Indeed, NHS trusts and local organisations, tasked with 
equitable delivery of healthcare deny the findings based on data, which they 
have supplied. National organisations, such as the Care Quality 
Commission and NHS Improvement, do not recognise their statutory 
obligations and have conducted no studies to address these inequalities. 
Even the Equality and Human Rights Commission has taken no action on 
these issues and appears to have no active research programme related to 
equality of care within the NHS and hospital services, in particular. Against 
such a background, the only form of potential legal remedy, for a 
community, is through judicial review and, for an individual, through legal 
action in the tort of negligence.  
This research has raised a number of questions, which need to be addressed 
in future research, including: 




2. Why are government bodies reluctant to accept the evidence derived 
from their own data? 
3. What are the roles of various actors in this pattern of discriminatory 
care? The actors are: patients, doctors and managers. 
4. What legal remedies could be developed to address these inequalities 
and how could they be made sufficiently robust to overcome current 
institutional inertia in dealing with these issues? 
5. The best hope for addressing the inequalities in health that have been 
demonstrated in this research is through a new statutory requirement 
for the regular reporting of differences in management and outcomes 
by ethnicity for a range of named diseases. Trusts and Clinical 
Commissioning Groups then would be required to provide such data 
annually. Its mode of collection and validity would be assessed by an 
independent commissioner, such as the Parliamentary and Health 
Service Ombudsman, who would publish the results of their findings. 
The executive board and management of failing organisations would 
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